FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Clinical trials for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) trials appear
Sign up with your email to follow new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to plug kidney leaks in three tough diseases
Disease control Recruiting nowThis study tests an experimental drug called EVER001 in 45 adults with three types of kidney disease (FSGS, MCD, or IgA Nephropathy) that cause protein to leak into urine. Participants take four capsules daily for 52 weeks. The goal is to see if the drug safely reduces protein le…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: PHASE2 • Sponsor: Everest Medicines (China) Co.,Ltd. • Aim: Disease control
Last updated Jun 05, 2026 12:08 UTC
-
New hope for kidney disease patients: experimental drug enters advanced trial
Disease control Recruiting nowThis study tests an experimental drug called BAT4406F in people with two rare kidney conditions: Minimal Change Disease and Focal Segmental Glomerulosclerosis. The goal is to see if the drug can reduce protein in urine and prevent relapses. About 192 adults who have responded to …
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 01, 2026 17:53 UTC
-
New study aims to uncover hidden immune triggers in childhood kidney disease
Knowledge-focused Recruiting nowThis study looks at whether certain immune system proteins (autoantibodies) are involved in a kidney condition called nephrotic syndrome, which causes swelling and protein loss in urine. Researchers will test blood and kidney tissue from 50 children and adults to find these marke…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 02, 2026 11:40 UTC